Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares Outstanding
Ratios

Immunocore Holdings (IMCR) Accumulated Depreciation & Amortization (2022 - 2025)

Immunocore Holdings (IMCR) has disclosed Accumulated Depreciation & Amortization for 4 consecutive years, with $3.1 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization fell 26.19% to $3.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.1 million through Dec 2025, down 26.19% year-over-year, with the annual reading at $3.1 million for FY2025, 26.19% down from the prior year.
  • Accumulated Depreciation & Amortization hit $3.1 million in Q4 2025 for Immunocore Holdings, down from $4.2 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $5.3 million in Q4 2022 to a low of $3.1 million in Q4 2025.
  • Historically, Accumulated Depreciation & Amortization has averaged $4.2 million across 4 years, with a median of $4.1 million in 2023.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: rose 2.44% in 2024 and later decreased 26.19% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $5.3 million in 2022, then decreased by 22.64% to $4.1 million in 2023, then increased by 2.44% to $4.2 million in 2024, then decreased by 26.19% to $3.1 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for IMCR at $3.1 million in Q4 2025, $4.2 million in Q4 2024, and $4.1 million in Q4 2023.